EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage

Lu Zhang, Alexandra Dopfer-Jablonka iD, Inga Nehlmeier, Amy Kempf, Luise Graichen, Noemí Calderón Hampel, Anne Cossmann, Metodi V Stankov, Gema Morillas Ramos iD, Sebastian R Schulz iD, Hans-Martin Jäck iD, Georg M N Behrens iD und 2 weitere

Vaccines · 01.05.2024 · 12 (5) · 487

DOI: 10.3390/vaccines12050487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 01.05.2024. Verfasst von Lu Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Infection Biology Unit, German Primate Center-Leibniz Institute for Primate Research, 37077 Göttingen, Germany. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, Niedersächsisches Ministerium für Wissenschaft und Kultur, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transmissibility and immune evasion of the recently emerged, highly mutated SARS-CoV-2 BA.2.87.1 are unknown. Here, we report that BA.2.87.1 efficiently enters human cells but is more sensitive to antibody-mediated neutralization than the currently dominating JN.1 variant. Acquisition of adaptive mutations might thus be needed for efficient spread in the population.

Schlagwörter

Stichwörter der Autor:innen

ACE2 bindingBA.2.87.1SARS-CoV-2antibody evasionhost cell entryspike protein

Autor:innen und Institutionen

  • Infection Biology Unit, German Primate Center-Leibniz Institute for Primate Research, 37077 Göttingen, Germany.
  • Faculty of Biology and Psychology, Georg-August-University Göttingen, 37073 Göttingen, Germany.
  • Department of Rheumatology and Immunology, Hannover Medical School, 30625 Hannover, Germany.
  • German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 30625 Hannover, Germany.
  • Division of Molecular Immunology, Department of Internal Medicine 3, Friedrich-Alexander University of Erlangen-Nürnberg, 91054 Erlangen, Germany.
  • Center for Individualized Infection Medicine (CiiM), 30625 Hannover, Germany.

ORCID-Profile: Alexandra Dopfer-Jablonka, Gema Morillas Ramos, Sebastian R Schulz, Hans-Martin Jäck, Georg M N Behrens, Stefan Pöhlmann, Markus Hoffmann

Förderung

  • European Commission
  • Niedersächsisches Ministerium für Wissenschaft und Kultur
  • Deutsche Forschungsgemeinschaft
  • European Union
  • China Scholarship Council
  • Federal Ministry of Education and Research
  • Bavarian State Ministry for Science and Art
  • Bavarian Research Foundation

Zitieren

APA

Zhang, L., Dopfer-Jablonka, A., Nehlmeier, I., Kempf, A., Graichen, L., Calderón Hampel, N., Cossmann, A., Stankov, M. V., Morillas Ramos, G., Schulz, S. R., Jäck, H. M., Behrens, G. M. N., Pöhlmann, S., & Hoffmann, M. (2024). Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage. Vaccines, 12(5), 487. https://doi.org/10.3390/vaccines12050487

Vancouver

Zhang L, Dopfer-Jablonka A, Nehlmeier I, Kempf A, Graichen L, Calderón Hampel N, et al. Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage. Vaccines. 2024;12(5):487. doi:10.3390/vaccines12050487

BibTeX
@article{Zhang2024,
  author = {Zhang, Lu and Dopfer-Jablonka, Alexandra and Nehlmeier, Inga and Kempf, Amy and Graichen, Luise and Calderón Hampel, Noemí and Cossmann, Anne and Stankov, Metodi V and Morillas Ramos, Gema and Schulz, Sebastian R and Jäck, Hans-Martin and Behrens, Georg M N and Pöhlmann, Stefan and Hoffmann, Markus},
  title = {Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage},
  journal = {Vaccines},
  year = {2024},
  volume = {12},
  number = {5},
  pages = {487},
  doi = {10.3390/vaccines12050487}
}
Kostenlos starten →